The shares of the firm were trading 2.99 per cent up at Rs 531.40 apiece at 10.38 am on Monday. In a span of five days, the firm's shares went up 4.96 per cent, while it had zoomed 12.82 per cent in a period of one month.
The pharma's revenue went up 16 per cent to Rs 6,297 crore during the quarter reviewed, over the figure in the corresponding period the previous year. Its Ebitda went up 25.9 per cent to Rs. 1,631 crore while its gross margin was at 57.2 per cent in Q4 FY23.
The company posted a 25.5 per cent growth in total revenue to Rs. 11,569 crore in third quarter, against Rs 9,218 crore in the same period last year, according to the statement uploaded on its website.
The software giant had announced its corporate earnings on Monday. In a span of five days, the shares of the company declined 0.69 per cent while it dipped 0.20 per cent in a span of 30 days.